Hirooka, Masashi

Performance of non-invasive tests and histology for the prediction of clinical outcomes in patients with non-alcoholic fatty liver disease: an individual participant data meta-analysis

Mózes, F. E., Lee, J. A., Vali, Y., Alzoubi, O., Staufer, K., Trauner, M., Paternostro, R., Stauber, R. E., Holleboom, A. G., van Dijk, A.-M., et al. (2023) · The Lancet Gastroenterology & Hepatology

Liver Disease Diagnosis and TreatmentLiver Disease and Transplantation

Cited by 214

Accuracy of spleen stiffness measurement for the diagnosis of clinically significant portal hypertension in patients with compensated advanced chronic liver disease: a systematic review and individual patient data meta-analysis

Dajti, E., Ravaioli, F., Zykus, R., Rautou, P.-E., Elkrief, L., Grgurevic, I., Stefanescu, H., Hirooka, M., Fraquelli, M., Rosselli, M., et al. (2023) · The Lancet Gastroenterology & Hepatology

Liver Disease and TransplantationLiver Disease Diagnosis and Treatment

Cited by 109

B Cell-Activating Factor is Associated With the Histological Severity of Nonalcoholic Fatty Liver Disease

Miyake, T., Abe, M., Tokumoto, Y., Hirooka, M., Furukawa, S., Kumagi, T., Hamada, M., Kawasaki, K., Tada, F., Ueda, T., et al. (2013) · Hepatology International

Liver Disease Diagnosis and TreatmentLiver physiology and pathology

Cited by 59

Depletion of B cell‐activating factor attenuates hepatic fat accumulation in a murine model of nonalcoholic fatty liver disease

Nakamura, Y., Abe, M., Kawasaki, K., Miyake, T., Watanabe, T., Yoshida, O., Hirooka, M., Matsuura, B., & Hiasa, Y. (2019) · Scientific Reports

Adipokines, Inflammation, and Metabolic DiseasesLiver Disease Diagnosis and Treatment

Cited by 34